EBITDA Multiples by Industry: India 2026

Sector	EBITDA Range (2026)
SaaS / high-growth digital	12–25x
IT services / BPO / KPO	10–18x
Pharmaceuticals / specialty pharma	10–18x
Healthcare services (hospitals, diagnostics)	8–14x
Financial services / fintech	8–15x
Consumer / FMCG	7–12x
Education (K-12, EdTech, higher education)	6–12x
Auto ancillaries / specialty manufacturing	6–10x
Professional services	5–9x
General manufacturing	5–8x
Staffing / HR services	4–7x

$5M–$50M EBITDA, competitive process, H1 2026. See full sector breakdown below.

India’s mid-market M&A generates some of the highest EBITDA multiples in Asia Pacific, driven by high-growth sectors, deep PE capital, and sustained inbound strategic buyer demand from the US, Europe, and Japan. Technology and IT services businesses command 10–18x, pharmaceuticals 10–18x, and consumer/FMCG 7–12x. Lyndon Advisory advises Indian promoters and business owners through structured sell-side processes across these sectors.

“India stands apart in APAC M&A for the depth of its PE ecosystem and the breadth of inbound strategic buyer interest. For mid-market business owners and promoters, this means genuine competitive tension at the offer stage — if the process is structured correctly. A bilateral approach leaves significant value on the table compared to a managed, multi-buyer process.”

— Daniel Bae, Founder & CEO, Lyndon Advisory ($30B+ transaction experience)

For the broader valuation framework behind these benchmarks, see Lyndon’s M&A valuation guide.

For India market context — sectors, buyer universe, regulatory environment, and seller next steps — see the India M&A market 2026 overview.

Market data: Bain & Company’s Asia-Pacific Private Equity Report 2026 tracks India PE deployment and exit trends. EY India M&A Insights provides deal value and volume benchmarks across sectors. India’s M&A market exceeded $90 billion in deal value in 2025, driven by technology, financial services, and consumer sector consolidation.

What to Do With Your Sector Multiple

Situation	Next step
You know your sector range and want an indicative valuation for your business	Submit a confidential valuation inquiry
A PE fund, strategic buyer, or foreign acquirer has approached you	Get a buyer-approach review
You want to see what Lyndon charges before starting a process	See the fee structure
You are 12–18 months away from a sale and want to know what to fix first	Check your exit readiness

How EBITDA Multiples Work in India

An EBITDA multiple expresses how many years of normalised EBITDA a buyer is willing to pay to acquire a business. A business with ₹400M EBITDA selling at 10x achieves an enterprise value of ₹4 billion.

Indian multiples reflect several factors that differ from other APAC markets:

• Growth premium — India’s GDP growth of 6–7% gives buyers a higher-growth earnings base to underwrite, producing structurally higher multiples than slower-growth markets
• PE ecosystem depth — India has more active PE buyers per deal than most APAC markets, creating genuine competitive tension at the offer stage
• Inbound strategic demand — US, European, Japanese, and Middle Eastern acquirers compete for Indian assets as part of broader Asia strategies, adding a second buyer pool alongside domestic consolidators
• Sector concentration — multiples vary more sharply between sectors in India than in developed markets, with technology and pharma commanding premium multiples and cyclical businesses receiving discounts
• Process quality — a competitive process with multiple bidders consistently achieves 15–25% higher multiples than bilateral negotiations, according to Deloitte’s analysis of mid-market transactions

For a cross-market comparison of APAC EBITDA multiples, see EBITDA multiples by industry: Australia 2026, Japan 2026, and Singapore 2026.

India EBITDA Multiples by Sector (2026)

The following table represents current H1 2026 mid-market Indian transaction multiples for businesses with $5M–$50M EBITDA sold through competitive processes.

Sector	EBITDA Multiple Range	Key Multiple Drivers
SaaS / high-growth digital	12–25x	ARR growth, net revenue retention, global customer base
IT services / BPO / KPO	10–18x	Revenue recurrence, delivery quality, global client diversity
Pharmaceuticals / specialty pharma	10–18x	US FDA filings, proprietary molecules, regulated market approvals
Healthcare services (hospitals, diagnostics)	8–14x	Location portfolio, NABH accreditation, payer mix
Financial services / fintech	8–15x	AUM, loan book quality, RBI licensing, regulatory position
Consumer / FMCG	7–12x	Brand strength, distribution depth, category leadership
Education (K-12, EdTech, higher education)	6–12x	NAAC/AICTE accreditation, enrolment trends, repeat revenue
Auto ancillaries / specialty manufacturing	6–10x	OEM relationships, exports revenue, proprietary product
Professional services	5–9x	Client diversity, government revenue, IP ownership
General manufacturing	5–8x	Customer concentration, asset condition, export mix
Staffing / HR services	4–7x	Permanent vs contract mix, sector specialisation

Sources: Lyndon Advisory transaction pipeline; Bain Asia-Pacific PE Report 2026; EY India M&A Insights 2025–2026; KPMG India M&A Trends. Ranges represent competitive process outcomes for businesses with $5M–$50M EBITDA.

Sector-by-Sector Detail

Technology and IT Services

Technology is India’s highest-multiple sector and the most active M&A segment by deal value. SaaS businesses with strong ARR growth, high net revenue retention, and global customer bases command EBITDA multiples of 12–25x — or 5–12x ARR for businesses valued primarily on a revenue basis.

IT services and outsourcing businesses — BPO, KPO, engineering services, software product development — trade at 10–18x EBITDA, reflecting strong client relationships, recurring project-based revenue, and deep execution talent that is difficult to replicate. Key value drivers: multi-year contract tenure, US or European client diversification, and proprietary delivery frameworks.

Active buyers include US technology companies building India capabilities, European firms in automotive and engineering services, domestic IT listed companies (Infosys, Wipro, HCL, Tech Mahindra) acquiring specialist capabilities, and growth-focused PE funds such as TA Associates, Warburg Pincus, General Atlantic, and Sofina.

Pharmaceuticals and Healthcare

India’s pharmaceutical sector generates some of the most competitive M&A internationally. Specialty pharmaceutical businesses with US FDA-approved facilities, proprietary generic formulations, or pipeline assets command 10–18x EBITDA, with premium multiples for businesses with US market exposure or complex molecule manufacturing capability.

Healthcare services — hospital networks, diagnostic chains, specialty clinics — trade at 8–14x EBITDA. PE roll-up strategies in Indian healthcare have been active since 2018, and the buyer market now includes Manipal Health, Aster DM, Blackstone-backed platform companies, and international hospital groups building India positions.

Consumer and FMCG

Branded consumer and FMCG businesses in India trade at 7–12x EBITDA, with premium multiples for businesses with strong regional brands, deep distribution networks, or category leadership in sub-segments. The India consumer opportunity continues to attract both domestic strategic acquirers (HUL, ITC, Godrej Consumer, Dabur) and international groups (Nestlé, Unilever, Reckitt) seeking portfolio expansion in the Indian market.

Financial Services and Fintech

India’s financial services M&A is complex due to RBI licensing and regulatory requirements. NBFCs and microfinance institutions are often valued on book value multiples (1.5–3x) rather than EBITDA. Wealth management, insurance distribution, and fintech businesses with recurring revenue trade at 8–15x EBITDA depending on AUM scale, customer lifetime value, and licensing position.

Manufacturing and Auto Ancillaries

Manufacturing multiples in India range from 5–10x for specialty or auto-linked businesses down to 4–7x for general manufacturing. Auto ancillary businesses with OEM relationships — particularly those supplying global automotive platforms — achieve premiums, as Japanese, Korean, and European OEM suppliers compete for India-based manufacturing scale. Specialty chemical and agrochemical businesses trade at 6–10x.

India-Specific Factors Affecting Multiples

Promoter Dependence

The most common multiple-compressor in Indian M&A is promoter dependence — businesses where the founding family or promoter group is the primary relationship-holder, credit-approver, and operating decision-maker. Buyers apply 20–30% discounts to promoter-dependent businesses. A structured management transition plan, second-tier leadership, and documented operating procedures close this gap.

Financial Documentation

Indian SMEs often present financials with complex structures: multiple entities, off-balance-sheet items, undisclosed related-party transactions, and EBITDA requiring significant normalisation. Buyers facing a lengthy normalisation process apply risk discounts. Sellers who prepare three years of audited, clean financials with documented add-backs achieve materially better pricing.

Regulatory Approval Complexity

Sectors such as pharmaceuticals, financial services, media, and telecom require CCI, RBI, IRDAI, or sector-specific regulatory approval. This approval requirement extends deal timelines and can limit the buyer universe to parties with the capacity to manage Indian regulatory processes. For sellers in regulated sectors, identifying pre-qualified buyers before going to market reduces process risk.

Process Structure

India’s large domestic PE ecosystem — with Blackstone, KKR, Bain Capital, Apax, TPG, Warburg Pincus, ChrysCapital, and many mid-market funds all active — means that competitive auction processes attract genuine multiple bidders. Sellers who run bilateral negotiations with the first interested party consistently leave 20–30% on the table versus those who structure a properly managed competitive process.

For the full sell-side process in India, see how to sell a business in India and Lyndon’s M&A process guide.

What Lyndon Advisory Does in India

Lyndon Advisory manages sell-side transactions for Indian business owners and promoters: financial normalisation, investment story, buyer mapping across PE funds and strategic acquirers, CIM preparation, buyer outreach and confidentiality management, offer evaluation, and negotiation through to closing.

Fee structure: 2% of enterprise value, capped at US$300,000. No retainer, no monthly fee, no expense recharge. You pay nothing unless a transaction closes.

Submit a confidential valuation inquiry →